Table of contents

Clinical and epidemiological research

• Extended report: Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis (12 December, 2012)

  Gerd R Burmester, Michael E Weinblatt, Iain B McInnes, Duncan Porter, Olga Barbarash, Mykola Vatutin, Istvan Szombati, Ehsanollah Esfandiari, Matthew A Sleeman, Christopher D Kane, Guy Cavet, Bing Wang, Alex Godwood, Fabio Magrini, for the EARTH Study Group
• Extended report: A phase 2 dose-ranging study of subcutaneous tabalumab for the treatment of patients with active rheumatoid arthritis and an inadequate response to methotrexate (18 April, 2013) Free

  Mark C Genovese, Eric Lee, Julie Satterwhite, Melissa Veenhuizen, Damon Disch, Pierre-Yves Berclaz, Stephen Myers, Gregory Sides, Olivier Benichou
• Extended report: Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors (25 December, 2012) Free

  Mark C Genovese, Roy M Fleischmann, Maria Greenwald, Julie Satterwhite, Melissa Veenhuizen, Li Xie, Pierre-Yves Berclaz, Stephen Myers, Olivier Benichou
• Extended report: Long-term safety of pegloticase in chronic gout refractory to conventional treatment (10 November, 2012)

  Michael A Becker, Herbert S B Baraf, Robert A Yood, Aileen Dillon, Janitzia Vázquez-Mellado, Faith D Ottery, Dinesh Khanna, John S Sundy
• Extended report: Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in ankylosing spondylitis (14 September, 2012)

  Ejaz Pathan, Sonya Abraham, Elizabeth Van Rossen, Robin Withrington, Andrew Keat, Peter J Charles, Erin Paterson, Muslima Chowdhury, Catherine McClinton, Peter C Taylor
• Extended report: Increased IL-17A expression in temporal artery lesions is a predictor of sustained response to glucocorticoid treatment in patients with giant-cell arteritis (19 September, 2012)

  Georgina Espígol-Frigolé, Marc Corbera-Bellalta, Ester Planas-Rigol, Ester Lozano, Marta Segarra, Ana García-Martínez, Sergio Prieto-González, José Hernández-Rodríguez, Josep M Grau, Mahboob U Rahman, Maria C Cid
• Extended report: Golimumab monotherapy in Japanese patients with active rheumatoid arthritis despite prior treatment with disease-modifying antirheumatic drugs: results of the phase 2/3, multicentre, randomised, double-blind, placebo-controlled GO-MONO study through 24 weeks (14 September, 2012)

  Tsutomu Takeuchi, Masayoshi Harigai, Yoshiya Tanaka, Hisashi Yamanaka, Naoki Ishiguro, Kazuhiko Yamamoto, Nobuyuki Miyasaka, Takao Koike, Minoru Kanazawa, Takuya Oba, Toru Yoshinari, Daniel Baker, the GO-MONO study group
• Extended report: Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients (7 November, 2012)

  Ronald F van Vollenhoven, Paul Emery, Clifton O Bingham, Edward C Keystone, Roy M Fleischmann, Daniel E Furst, Nicola Tyson, Neil Collinson, Patricia B Lehane
• Extended report: Therapeutic approaches for the treatment of renal disease in juvenile systemic lupus erythematosus: an international multicentre PRINTO study (25 October, 2012)

  Paivi M Miettunen, Angela Pistorio, Elena Palmisani, Angelo Ravelli, Earl Silverman, Sheila Oliveira, Maria Alessio, Ruben Cuttica, Dimitrina Mihaylova, Graciela Espada, Srdjan Pasic, Antonella Insalaco, Seza Ozen, Oscar Porras, Flavio Sztajnbok, Dragana Lazarevic, Alberto Martini, Nicolino Ruperto, for the Paediatric Rheumatology International Trials Organisation (PRINTO)
• Extended report: Genome-wide association study identifies GIMAP as a novel susceptibility locus for Behçet's disease (6 October, 2012)

  Yun Jong Lee, Yukihiro Horie, Graham R Wallace, Yong Seok Choi, Ji Ah Park, Ji Yong Choi, Ran Song, Young-Mo Kang, Seong Wook Kang, Han Joo Baek, Nobuyoshi Kitaichi, Akira Meguro, Nobuhisa Mizuki, Kenichi Namba, Susumu Ishida, Jinhyun Kim, Edyta Niemczyk, Eun Young Lee, Yeong Wook Song, Shigeaki Ohno, Eun Bong Lee
• Extended report: Demographic and disease-related predictors of abnormal lung function in patients with established inflammatory polyarthritis and a comparison with the general population (13 October, 2012)

  Suzanne M M Verstappen, Mark Lunt, Robert N Luben, Jackie Chipping, Tarnya Marshall, Kay-Tee Khaw, Nick Wareham, William G Dixon, Ian N Bruce, Deborah P M Symmons
• Extended report: Why the findings of published multiple treatment comparison meta-analyses of biologic treatments for rheumatoid arthritis are different: an overview of recurrent methodological shortcomings (20 October, 2012)

  Kristian Thorlund, Eric Druyts, J Antonio Aviña-Zubieta, Ping Wu, Edward J Mills
• Concise report: Predictors of preterm birth in patients with mild systemic lupus erythematosus (29 January, 2013)

  Megan E B Clowse, Daniel J Wallace, Michael Weisman, Andra James, Lisa G Criscione-Schreiber, David S Pisetsky
• Concise report: MRI of hand and foot joints of patients with anticitrullinated peptide antibody positive arthralgia without clinical arthritis (19 January, 2013)

  Annemarie Krabben, Wouter Stomp, Désirée M F M van der Heijde, Jessica A B van Nies, Johan L Bloem, Tom W J Huizinga, Monique Reijnierse, Annette H M van der Helm-van Mil
• Concise report: Tendon involvement in the feet of patients with gout: a dual-energy CT study (19 January, 2013)

  Nicola Dalbeth, Ramanamma Kalluru, Opetaia Aati, Anne Horne, Anthony J Doyle, Fiona M McQueen